VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
44 hedge funds and large institutions have $36.6M invested in Viracta Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
30% more call options, than puts
Call options by funds: $86K | Put options by funds: $66K
10% more funds holding
Funds holding: 40 → 44 (+4)
Holders
44
Holding in Top 10
3
Calls
$86K
Puts
$66K
Top Buyers
| 1 | +$6.07M | |
| 2 | +$4.56M | |
| 3 | +$4.5M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$1.07M |
| 5 |
FI
Fosun International
Hong Kong,
China
|
+$863K |
Top Sellers
| 1 | -$166K | |
| 2 | -$132K | |
| 3 | -$117K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$56K |
| 5 |
Two Sigma Investments
New York
|
-$15K |